微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 4.11% | 17.43% | 50.55% | 31/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | 2.73% | 12.35% | -60.09% | 27/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 6.84% | -12.31% | 14% | 42/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 6% | -11.37% | 71.43% | 47/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 3.5% | -29.58% | 44.03% | 49/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 2.43% | -26.36% | -68.85% | 35/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 7.8% | -19.09% | 15.21% | 45/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 6.77% | -26.25% | 36.22% | 45/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 4.97% | -14.31% | 50.61% | 38/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 3.3% | -30.96% | -65.77% | 19/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 9.64% | -52.11% | 5.01% | 35/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 9.18% | -55.63% | 58.28% | 32/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 5.8% | -60.3% | 21.34% | 38/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 4.78% | -53.05% | -76.25% | 18/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 20.13% | 6.96% | -2.71% | 28/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 20.69% | 57.1% | 41.62% | 22/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 14.61% | 79.93% | 43.52% | 20/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 10.18% | 203.88% | -45.91% | 15/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 18.82% | 30.6% | 42.9% | 44/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 13.17% | 12.56% | 62.19% | 46/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 8.12% | 55.56% | 142.39% | 50/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 3.35% | 27.38% | -76.75% | 49/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 14.41% | -27.88% | 23.16% | 67/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 11.7% | -16.67% | 124.14% | 50/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 5.22% | -43.51% | 98.48% | 70/141 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 2.63% | -57.03% | -86.84% | 32/141 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 19.98% | 16.3% | 42.31% | 39/141 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 14.04% | -5.77% | 51.95% | 17/141 | 10.54% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 9.24% | -4.45% | 50.98% | 17/141 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 6.12% | 8.32% | -64.38% | 5/141 | 2.73% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 17.18% | -32.84% | 15.3% | 41/141 | 14.23% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 14.9% | -43.37% | 54.08% | 10/141 | 9.71% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 9.67% | -58.16% | 71.15% | 8/141 | 4.54% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 5.65% | -50.18% | -77.91% | 3/141 | 2.78% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 25.58% | -35.79% | -2.77% | 21/141 | 14.51% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 26.31% | 2% | 13.85% | 2/141 | 9.49% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 23.11% | 2% | 103.79% | 1/141 | 6.11% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 11.34% | -7.2% | -71.54% | 1/141 | 2.74% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 39.84% | -16.53% | -16.53% | 4/141 | 16.44% | 奥泰生物 | 76.87% | 行业排名> |